Rytuksymab (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Rytuksymab" in Polish language version.

refsWebsite

Global rank Polish rank

2^nd place

6^th place

4^th place

7^th place

68^th place

31^st place

doi.org

RP. Taylor, MA. Lindorfer. Drug insight: the mechanism of action of rituximab in autoimmune disease--the immune complex decoy hypothesis. „Nat Clin Pract Rheumatol”. 3 (2), s. 86-95, 2007. DOI: 10.1038/ncprheum0424. PMID: 17299446.
Davies, Andrew, Merli, Francesco, Mihaljevic, Biljana, Siritanaratkul, Noppadol i inni. Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study. „The Lancet Oncology”. 15 (3), s. 343-352, 2014. DOI: 10.1016/S1470-2045(14)70005-1.
M. Covelli, P. Sarzi-Puttini, F. Atzeni, P. Macchioni. Safety of rituximab in rheumatoid arthritis. „Reumatismo”. 62 (2). s. 101-106. DOI: 10.4081/reumatismo.2010.101. PMID: 20657886.

RP. Taylor, MA. Lindorfer. Drug insight: the mechanism of action of rituximab in autoimmune disease--the immune complex decoy hypothesis. „Nat Clin Pract Rheumatol”. 3 (2), s. 86-95, 2007. DOI: 10.1038/ncprheum0424. PMID: 17299446.
E. Dotan, C. Aggarwal, MR. Smith. Impact of Rituximab (Rituxan) on the Treatment of B-Cell Non-Hodgkin's Lymphoma. „P T”. 35 (3), s. 148-157, 2010. PMID: 20442809. PMCID: PMC2844047.
M. Covelli, P. Sarzi-Puttini, F. Atzeni, P. Macchioni. Safety of rituximab in rheumatoid arthritis. „Reumatismo”. 62 (2). s. 101-106. DOI: 10.4081/reumatismo.2010.101. PMID: 20657886.